New patent expiration for Merck Sharp drug TEMODAR
Annual Drug Patent Expirations for TEMODAR Temodar is a drug marketed by Merck Sharp Dohme and is included in two […]
New patent expiration for Merck Sharp drug TEMODAR Read Post »
Patent Expiration
New patent expiration for Evofem Inc drug PHEXXI
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA.
New patent expiration for Evofem Inc drug PHEXXI Read Post »
New patent expiration for Averitas drug QUTENZA
Annual Drug Patent Expirations for QUTENZA Qutenza is a drug marketed by Averitas and is included in one NDA. It
New patent expiration for Biogen Idec drug SPINRAZA
Annual Drug Patent Expirations for SPINRAZA Spinraza is a drug marketed by Biogen Idec and is included in one NDA.
New patent expiration for Biogen Idec drug SPINRAZA Read Post »
New patent expiration for Kastle Theraps drug KYNAMRO
Annual Drug Patent Expirations for KYNAMRO Kynamro is a drug marketed by Kastle Theraps Llc and is included in one
New patent expiration for Kastle Theraps drug KYNAMRO Read Post »
New patent expiration for Akcea Theraps drug TEGSEDI
Annual Drug Patent Expirations for TEGSEDI Tegsedi is a drug marketed by Akcea Theraps and is included in one NDA.
New patent expiration for Akcea Theraps drug TEGSEDI Read Post »
Drug Patent Expirations for the Week of September 3, 2023
QUTENZA (capsaicin) Averitas Patent: 10,869,827 Expiration: Sep 5, 2023 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of September 3, 2023 Read Post »
Drug Patent Expirations for the Week of September 3, 2023
QUTENZA (capsaicin) Averitas Patent: 10,869,827 Expiration: Sep 5, 2023 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of September 3, 2023 Read Post »
New patent expiration for Abbvie drug LATISSE
Annual Drug Patent Expirations for LATISSE Latisse is a drug marketed by Abbvie and is included in one NDA. It
